Home LiteratureArticle Details
PMID: 8995604 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.

Journal of virology ·Vol. 71 ·No. 2 ·1997-02-00 ·Pages 883-90

Platt EJ, Madani N, Kozak SL, Kabat D

Abstract

Recent evidence suggests that primary patient isolates of T-cell-tropic human immunodeficiency virus type 1 (HIV-1 ) have lower affinities for CD4 than their laboratory-adapted derivatives, that this may partly result from tighter gp120-gp41 bonds that constrain the CD4 binding sites of the primary viruses, and that selection for increased CD4 affinity may be the principal factor in laboratory adaptation of HIV-1 (S. L. Kozak, E. J. Platt, N. Madani, F. E. Ferro, Jr., K. Peden, and D. Kabat, J. Virol. 71:873-882, 1997). These conclusions were based on studies with a panel of HeLa-CD4 cell clones that differ in CD4 levels over a broad range, with laboratory-adapted viruses infecting all clones with equal efficiencies and primary T-cell-tropic viruses infecting the clones in proportion to cellular CD4 levels. Additionally, all of the primary and laboratory-adapted T-cell-tropic viruses efficiently used CXCR-4 (fusin) as a coreceptor. To test these conclusions by an independent approach, we studied mutations in the laboratory-adapted virus LAV/IIIB that alter the CD)4 binding region of gp120 and specifically reduce CD4 affinities of free gp 120 by 85 to 98% (U. Olshevsky et al., J. Virol. 64:5701-5707, 1990). These mutations reduced virus titers to widely varying extents that ranged from severalfold to several orders of magnitude and converted infectivities on the HeLa-CD4 panel from CD4 independency to a high degree of CD4 dependency that resembled the behavior of primary patient viruses. The relative infectivities of the mutants correlated closely with their sensitivities to inactivation by soluble CD4 but did not correlate with the relative CD4 affinities of their free gp120s. Most of the mutations did not substantially alter envelope glycoprotein synthesis, processing, expression on cell surfaces, incorporation into virions, or rates of gp120 shedding from virions. However, one mutation (D457R) caused a decrease in gp160 processing by approximately 80%. The fact that several mutations increased rates of spontaneous viral inactivation (especially D368P) suggests that HIV-1 life spans may be determined by structural stabilities of viral envelope glycoproteins. All of the wild-type and mutant viruses were only slowly and inefficiently adsorbed onto cultured CD4-positive cells at 37 degrees C, and the gradual declines in viral titers in the media were caused almost exclusively by spontaneous inactivation rather than by adsorption. The extreme inefficiency with which infectious HIV-1 is able to infect cultured susceptible CD4-positive cells in standard assay conditions casts doubt on previous inferences that the vast majority of retrovirions produced in cultures are noninfectious. Apparent infectivity of T-cell-tropic HIV-1 in culture is limited by productive associations with CD4 and is influenced in an interdependent manner by CD4 affinities of viral gp120-gp41 complexes and quantities of cell surface CD4.

MeSH Terms
Acquired Immunodeficiency Syndrome/virology Binding Sites/genetics,immunology CD4 Antigens/immunology HIV Envelope Protein gp120/genetics,immunology HIV-1/genetics,immunology,pathogenicity HeLa Cells Humans Mutation Virulence/genetics
Chemicals
CD4 Antigens HIV Envelope Protein gp120
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Platt E J
Department of Biochemistry and Molecular Biology, Oregon Health Sciences University, Portland 97201-3098, USA.
Madani N
Kozak S L
Kabat D
References (41)
41 references, click to expand
  1. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.
    J Virol. 1991 Sep;65(9):5096-101 PMID: 1870213
  2. HIV requires multiple gp120 molecules for CD4-mediated infection.
    Nature. 1990 Jul 19;346(6281):277-9 PMID: 2374593
  3. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
    J Virol. 1992 Jan;66(1):235-43 PMID: 1727487
  4. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.
    J Virol. 1992 Feb;66(2):875-85 PMID: 1731112
  5. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1335-9 PMID: 1741386
  6. Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.
    J Virol. 1992 Jul;66(7):4445-51 PMID: 1602552
  7. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.
    Virology. 1992 Aug;189(2):695-714 PMID: 1386485
  8. Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers.
    J Virol. 1992 Sep;66(9):5610-4 PMID: 1501294
  9. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
    Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10792-6 PMID: 1438278
  10. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.
    J Virol. 1988 Nov;62(11):4414-9 PMID: 2459416
  11. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
    Nature. 1996 Jun 20;381(6584):667-73 PMID: 8649512
  12. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
    Proc Natl Acad Sci U S A. 1990 Sep;87(17):6574-8 PMID: 2395859
  13. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.
    Cell. 1996 Jun 28;85(7):1135-48 PMID: 8674119
  14. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.
    Cell. 1996 Jun 28;85(7):1149-58 PMID: 8674120
  15. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Science. 1996 Jun 28;272(5270):1955-8 PMID: 8658171
  16. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
    J Virol. 1997 Feb;71(2):873-82 PMID: 8995603
  17. A new technique for the assay of infectivity of human adenovirus 5 DNA.
    Virology. 1973 Apr;52(2):456-67 PMID: 4705382
  18. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.
    Cell. 1986 Jul 4;46(1):63-74 PMID: 2424612
  19. Highly sensitive immunoadsorption procedure for detection of low-abundance proteins.
    Anal Biochem. 1986 Jul;156(1):126-35 PMID: 3017145
  20. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    J Virol. 1988 Jun;62(6):2026-32 PMID: 3130494
  21. Biologically diverse molecular variants within a single HIV-1 isolate.
    Nature. 1988 Aug 4;334(6181):444-7 PMID: 2841608
  22. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual.
    J Virol. 1988 Nov;62(11):4078-85 PMID: 3172338
  23. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.
    J Virol. 1990 Nov;64(11):5270-6 PMID: 2214018
  24. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
    J Virol. 1990 Dec;64(12):5701-7 PMID: 2243375
  25. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Science. 1990 Nov 23;250(4984):1139-42 PMID: 2251501
  26. Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients.
    J Infect Dis. 1991 Jan;163(1):64-70 PMID: 1984477
  27. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
    J Virol. 1991 Feb;65(2):852-60 PMID: 1898972
  28. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93 PMID: 2006155
  29. Blocking of human immunodeficiency virus infection depends on cell density and viral stock age.
    J Virol. 1991 Jun;65(6):3293-300 PMID: 1674549
  30. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    J Exp Med. 1991 Aug 1;174(2):407-15 PMID: 1713252
  31. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
    J Virol. 1991 Sep;65(9):5007-12 PMID: 1870209
  32. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
    J Virol. 1993 Dec;67(12):7383-93 PMID: 7693970
  33. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.
    J Virol. 1994 Feb;68(2):1029-39 PMID: 7904656
  34. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1.
    J Virol. 1994 Apr;68(4):2570-7 PMID: 8139036
  35. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera.
    J Virol. 1995 Jan;69(1):39-48 PMID: 7983734
  36. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.
    Nature. 1995 May 25;375(6529):291-8 PMID: 7753193
  37. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.
    J Virol. 1995 Jul;69(7):4413-22 PMID: 7769703
  38. Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process.
    J Virol. 1996 Jun;70(6):3432-9 PMID: 8648675
  39. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
    Science. 1996 May 10;272(5263):872-7 PMID: 8629022
  40. Identification of a major co-receptor for primary isolates of HIV-1.
    Nature. 1996 Jun 20;381(6584):661-6 PMID: 8649511
  41. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor.
    J Virol. 1991 Dec;65(12):6468-77 PMID: 1942243
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1997-02-00
Pages
883-90
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC191135
Subset
IM
Grants
NCI NIH HHS · CA67358 · United States
NIAID NIH HHS · I F32 AID9735-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]